Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized aminophylline for severe asthma attack in the emergency department
IRCT20141115019962N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of aminophylline in asthma (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Admission rate and Change in peak expiratory flow rate. Started Sep 2024; status: completed.
02
Drugs
aminophylline
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20141115019962N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141115019962N3.